{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:46:04Z","timestamp":1790660764212,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11695-025-08419-x","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T18:20:55Z","timestamp":1766427655000},"page":"804-817","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of Bariatric Surgery on the Pharmacokinetics of Cardiovascular Drugs: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3559-6022","authenticated-orcid":false,"given":"Yasaman","family":"Zarinfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2002-1170","authenticated-orcid":false,"given":"Sahba","family":"Babaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9593-1839","authenticated-orcid":false,"given":"Mohammad Javad","family":"Majidzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7254-0046","authenticated-orcid":false,"given":"Zeinab","family":"Masoumipoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3641-3010","authenticated-orcid":false,"given":"Azin","family":"Gheymati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4304-3997","authenticated-orcid":false,"given":"Vahid","family":"Eslami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"issue":"4","key":"8419_CR1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s13668-023-00498-5","volume":"12","author":"SK Konstantinidou","year":"2023","unstructured":"Konstantinidou SK, Argyrakopoulou G, Dalamaga M, Kokkinos A. The effects of bariatric surgery on pharmacokinetics of drugs: a review of current evidence. Curr Nutr Rep. 2023;12(4):695\u2013708.","journal-title":"Curr Nutr Rep"},{"key":"8419_CR2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.51681","author":"M Pakhare","year":"2024","unstructured":"Pakhare M, Anjankar A. Critical correlation between obesity and cardiovascular diseases and recent advancements in obesity. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.51681.","journal-title":"Cureus"},{"issue":"12","key":"8419_CR3","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1111\/bcp.14913","volume":"87","author":"JS Kingma","year":"2021","unstructured":"Kingma JS, Burgers DMT, Monpellier VM, Wiezer MJ, van Bluss\u00e9 HJ, Vaughns JD, et al. Oral drug dosing following bariatric surgery: general concepts and specific dosing advice. Br J Clin Pharmacol. 2021;87(12):4560\u201376.","journal-title":"Br J Clin Pharmacol"},{"issue":"19","key":"8419_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910375","volume":"25","author":"M Petrinovi\u0107","year":"2024","unstructured":"Petrinovi\u0107 M, Majeti\u0107 D, Bakula M, Pe\u0107in I, Fabris-Vitkovi\u0107 D, De\u0161kin M, et al. Molecular mechanisms affecting statin pharmacokinetics after bariatric surgery. Int J Mol Sci. 2024;25(19):10375.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"8419_CR5","first-page":"409","volume":"66","author":"S Lorico","year":"2020","unstructured":"Lorico S, Colton B. Medication management and pharmacokinetic changes after bariatric surgery. Can Fam Physician. 2020;66(6):409\u201316.","journal-title":"Can Fam Physician"},{"issue":"1","key":"8419_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s13679-023-00548-7","volume":"13","author":"E Dvo\u0159\u00e1\u010dkov\u00e1","year":"2024","unstructured":"Dvo\u0159\u00e1\u010dkov\u00e1 E, Pilkov\u00e1 A, Matoulek M, Slana\u0159 O, Hartinger JM. Bioavailability of orally administered drugs after bariatric surgery. Curr Obes Rep. 2024;13(1):141\u201353.","journal-title":"Curr Obes Rep"},{"issue":"8","key":"8419_CR7","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamasurg.2023.0252","volume":"158","author":"JH Kauppila","year":"2023","unstructured":"Kauppila JH, Markar S, Santoni G, Holmberg D, Lagergren J. Temporal changes in obesity-related medication after bariatric surgery vs no surgery for obesity. JAMA Surg. 2023;158(8):817\u201323.","journal-title":"JAMA Surg"},{"issue":"2","key":"8419_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.soard.2012.12.010","volume":"9","author":"JI Mechanick","year":"2013","unstructured":"Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient\u20142013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surg Obes Relat Dis. 2013;9(2):159\u201391.","journal-title":"Surg Obes Relat Dis"},{"issue":"8","key":"8419_CR9","doi-asserted-by":"publisher","first-page":"e13759","DOI":"10.1111\/obr.13759","volume":"25","author":"F Lajeunesse-Trempe","year":"2024","unstructured":"Lajeunesse-Trempe F, Okroj D, Ostarijas E, Ramalho A, Tremblay EJ, Llewellyn D, et al. Medication and supplement Pharmacokinetic changes following bariatric surgery: A systematic review and meta-analysis. Obes Rev. 2024;25(8):e13759.","journal-title":"Obes Rev"},{"key":"8419_CR10","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1007\/s11695-019-03885-6","volume":"29","author":"A El-Zailik","year":"2019","unstructured":"El-Zailik A, Cheung LK, Wang Y, Sherman V, Chow DS-L. Longitudinal impacts of gastric bypass surgery on pharmacodynamics and pharmacokinetics of statins. Obes Surg. 2019;29:2571\u201383.","journal-title":"Obes Surg"},{"issue":"9","key":"8419_CR11","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/phar.1632","volume":"35","author":"KJ Steffen","year":"2015","unstructured":"Steffen KJ, Wonderlich JA, Erickson AL, Strawsell H, Mitchell JE, Crosby RD. Comparison of warfarin dosages and international normalized ratios before and after Roux-en-Y gastric bypass surgery. Pharmacotherapy. 2015;35(9):876\u201380.","journal-title":"Pharmacotherapy"},{"issue":"2","key":"8419_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/10600280221105312","volume":"57","author":"PH Patel","year":"2023","unstructured":"Patel PH, Ho T, Upadhyay SM. A systematic review of warfarin use in post-bariatric surgery patients: cases compiled from a literature review. Ann Pharmacother. 2023;57(2):193\u20137.","journal-title":"Ann Pharmacother"},{"issue":"5","key":"8419_CR13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.amjmed.2016.12.033","volume":"130","author":"KA Martin","year":"2017","unstructured":"Martin KA, Lee CR, Farrell TM, Moll S. Oral anticoagulant use after bariatric surgery: a literature review and clinical guidance. Am J Med. 2017;130(5):517\u201324.","journal-title":"Am J Med"},{"issue":"7","key":"8419_CR14","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1111\/bcp.13243","volume":"83","author":"D Kr\u00f6ll","year":"2017","unstructured":"Kr\u00f6ll D, Stirnimann G, Vogt A, Lai DLL, Borb\u00e9ly YM, Altmeier J, et al. Pharmacokinetics and pharmacodynamics of single doses of rivaroxaban in obese patients prior to and after bariatric surgery. Br J Clin Pharmacol. 2017;83(7):1466\u201375.","journal-title":"Br J Clin Pharmacol"},{"key":"8419_CR15","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.thromres.2017.11.006","volume":"163","author":"A Rottenstreich","year":"2018","unstructured":"Rottenstreich A, Barkai A, Arad A, Raccah BH, Kalish Y. The effect of bariatric surgery on direct-acting oral anticoagulant drug levels. Thromb Res. 2018;163:190\u20135.","journal-title":"Thromb Res"},{"issue":"12","key":"8419_CR16","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/j.soard.2018.08.025","volume":"14","author":"D Kr\u00f6ll","year":"2018","unstructured":"Kr\u00f6ll D, Nett PC, Borb\u00e9ly YM, Sch\u00e4delin S, Calderara DB, Alberio L, Stirnimann G. The effect of bariatric surgery on the direct oral anticoagulant rivaroxaban: the extension study. Surg Obes Relat Dis. 2018;14(12):1890\u20136.","journal-title":"Surg Obes Relat Dis"},{"issue":"10","key":"8419_CR17","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1016\/j.jtha.2024.06.024","volume":"22","author":"C Leven","year":"2024","unstructured":"Leven C, Delavenne X, Roche C, Bressollette L, Couturaud F, Lacut K, et al. Full-dose rivaroxaban in patients with a history of bariatric surgery: bridging the knowledge gap through a phase 1 study. J Thromb Haemost. 2024;22(10):2844\u201354.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"8419_CR18","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.soard.2021.12.023","volume":"18","author":"KE Steele","year":"2022","unstructured":"Steele KE, Prokopowicz GP, Canner JP, Harris C, Jurao RA, Kickler TS, et al. The APB study: apixaban pharmacokinetics in bariatric patients before to 1 year after vertical sleeve gastrectomy or Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2022;18(5):594\u2013603.","journal-title":"Surg Obes Relat Dis"},{"issue":"5","key":"8419_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1177\/1060028017752426","volume":"52","author":"C Bolduc","year":"2018","unstructured":"Bolduc C, Flamand-Villeneuve J, Giroux I, Lebel S, Simard S, Picard F. Warfarin dose adjustment after biliopancreatic diversion\/duodenal switch bariatric surgery. Ann Pharmacother. 2018;52(5):425\u201330.","journal-title":"Ann Pharmacother"},{"issue":"7","key":"8419_CR20","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/jcph.2221","volume":"63","author":"PA Yamamoto","year":"2023","unstructured":"Yamamoto PA, Cristofoletti R, Vozmediano V, de Gaitani CM, da Silva RM, Kemp R, et al. Effect of roux-En\u2010Y gastric bypass in the pharmacokinetics of (R)\u2010carvedilol and (S)\u2010carvedilol. J Clin Pharmacol. 2023;63(7):838\u201347.","journal-title":"J Clin Pharmacol"},{"issue":"e1","key":"8419_CR21","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1136\/ejhpharm-2018-001804","volume":"27","author":"JP Yska","year":"2020","unstructured":"Yska JP, Wanders JT, Odigie B, Apers JA, Emous M, Tott\u00e9 ER, et al. Effect of Roux-en-Y gastric bypass on the bioavailability of metoprolol from immediate and controlled release tablets: a single oral dose study before and after surgery. Eur J Hosp Pharm. 2020;27(e1):e19\u201324.","journal-title":"Eur J Hosp Pharm"},{"issue":"5","key":"8419_CR22","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/bcp.12666","volume":"80","author":"I Gesquiere","year":"2015","unstructured":"Gesquiere I, Darwich AS, Van der Schueren B, de Hoon J, Lannoo M, Matthys C, et al. Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulations. Br J Clin Pharmacol. 2015;80(5):1021\u201330.","journal-title":"Br J Clin Pharmacol"},{"key":"8419_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s002280050724","volume":"56","author":"J W\u00f3jcicki","year":"2000","unstructured":"W\u00f3jcicki J, Wojciechowski G, W\u00f3jcicki M, Kostyrka R, Sterna R, Gawronska-Szklarz B, et al. Pharmacokinetics of propranolol and atenolol in patients after partial gastric resection: a comparative study. Eur J Clin Pharmacol. 2000;56:75\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"8419_CR24","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/clpt.2010.32","volume":"87","author":"I Skottheim","year":"2010","unstructured":"Skottheim I, Jakobsen G, Stormark K, Christensen H, Hjelmesaeth J, Jenssen T, et al. Significant increase in systemic exposure of Atorvastatin after biliopancreatic diversion with duodenal switch. Clin Pharmacol Ther. 2010;87(6):699\u2013705.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"8419_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/clpt.2009.82","volume":"86","author":"IB Skottheim","year":"2009","unstructured":"Skottheim IB, Stormark K, Christensen H, Jakobsen GS, Hjelmesaeth J, Jenssen T, et al. Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients. Clin Pharmacol Ther. 2009;86(3):311\u20138.","journal-title":"Clin Pharmacol Ther"},{"key":"8419_CR26","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1007\/s00464-012-2716-3","volume":"27","author":"GS Jakobsen","year":"2013","unstructured":"Jakobsen GS, Skottheim IB, Sandbu R, Christensen H, R\u00f8islien J, \u00c5sberg A, Hjelmes\u00e6th J. Long-term effects of gastric bypass and duodenal switch on systemic exposure of Atorvastatin. Surg Endosc. 2013;27:2094\u2013101.","journal-title":"Surg Endosc"},{"issue":"3","key":"8419_CR27","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/cpt.2056","volume":"109","author":"C Wegler","year":"2021","unstructured":"Wegler C, Prieto Garcia L, Klinting S, Robertsen I, Wi\u015bniewski JR, Hjelmes\u00e6th J, et al. Proteomics-informed prediction of rosuvastatin plasma profiles in patients with a wide range of body weight. Clin Pharmacol Ther. 2021;109(3):762\u201371.","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"8419_CR28","doi-asserted-by":"publisher","first-page":"e021878","DOI":"10.1136\/bmjopen-2018-021878","volume":"8","author":"J Hjelmes\u00e6th","year":"2018","unstructured":"Hjelmes\u00e6th J, \u00c5sberg A, Andersson S, Sandbu R, Robertsen I, Johnson LK, et al. Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL). BMJ Open. 2018;8(5):e021878.","journal-title":"BMJ Open"},{"issue":"5","key":"8419_CR29","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s40262-023-01235-5","volume":"62","author":"M Hovd","year":"2023","unstructured":"Hovd M, Robertsen I, Johnson LK, Krogstad V, Wegler C, Kvitne KE, et al. Neither gastric bypass surgery nor diet-induced weight-loss affect OATP1B1 activity as measured by Rosuvastatin oral clearance. Clin Pharmacokinet. 2023;62(5):725\u201335.","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"8419_CR30","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1007\/s11695-019-03885-6","volume":"29","author":"A El-Zailik","year":"2019","unstructured":"El-Zailik A, Cheung LK, Wang Y, Sherman V, Chow DSL. Longitudinal impacts of gastric bypass surgery on pharmacodynamics and pharmacokinetics of statins. Obes Surg. 2019;29(8):2571\u201383.","journal-title":"Obes Surg"},{"issue":"1","key":"8419_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1467-789X.2009.00614.x","volume":"11","author":"R Padwal","year":"2010","unstructured":"Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev. 2010;11(1):41\u201350.","journal-title":"Obes Rev"},{"issue":"4","key":"8419_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/phar.1560","volume":"35","author":"LN Chan","year":"2015","unstructured":"Chan LN, Lin YS, Tay-Sontheimer JC, Trawick D, Oelschlager BK, Flum DR, et al. Proximal Roux-en-Y gastric bypass alters drug absorption pattern but not systemic exposure of CYP3A4 and P-glycoprotein substrates. Pharmacotherapy. 2015;35(4):361\u20139.","journal-title":"Pharmacotherapy"},{"issue":"8","key":"8419_CR33","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1111\/jth.15358","volume":"19","author":"KA Martin","year":"2021","unstructured":"Martin KA, Beyer-Westendorf J, Davidson BL, Huisman MV, Sandset PM, Moll S. Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: updated communication from the ISTH SSC subcommittee on control of anticoagulation. J Thromb Haemost. 2021;19(8):1874\u201382.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"8419_CR34","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/bcp.12114","volume":"76","author":"VV Upreti","year":"2013","unstructured":"Upreti VV, Wang J, Barrett YC, Byon W, Boyd RA, Pursley J, et al. Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects. Br J Clin Pharmacol. 2013;76(6):908\u201316.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"8419_CR35","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1111\/jth.15823","volume":"20","author":"R Leong","year":"2022","unstructured":"Leong R, Chu DK, Crowther MA, Mithoowani S. Direct oral anticoagulants after bariatric surgery-what is the evidence? J Thromb Haemost. 2022;20(9):1988\u20132000.","journal-title":"J Thromb Haemost"},{"issue":"11","key":"8419_CR36","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/phar.1307","volume":"33","author":"AN Irwin","year":"2013","unstructured":"Irwin AN, McCool KH, Delate T, Witt DM. Assessment of warfarin dosing requirements after bariatric surgery in patients requiring long-term warfarin therapy. Pharmacotherapy. 2013;33(11):1175\u201383.","journal-title":"Pharmacotherapy"},{"issue":"0 1","key":"8419_CR37","first-page":"S1","volume":"21","author":"JI Mechanick","year":"2013","unstructured":"Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient\u20132013 update: cosponsored by American association of clinical Endocrinologists, the obesity society, and American society for metabolic & bariatric surgery. Obes (Silver Spring). 2013;21(0 1):S1\u201327.","journal-title":"Obes (Silver Spring)"},{"issue":"5","key":"8419_CR38","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/bcp.13054","volume":"82","author":"I Gesquiere","year":"2016","unstructured":"Gesquiere I, Hens B, Van der Schueren B, Mols R, de Hoon J, Lannoo M, et al. Drug disposition before and after gastric bypass: fenofibrate and posaconazole. Br J Clin Pharmacol. 2016;82(5):1325\u201332.","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"8419_CR39","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1007\/s11095-015-1752-9","volume":"32","author":"MJ Brill","year":"2015","unstructured":"Brill MJ, van Rongen A, van Dongen EP, van Ramshorst B, Hazebroek EJ, Darwich AS, et al. The pharmacokinetics of the CYP3A substrate midazolam in morbidly obese patients before and one year after bariatric surgery. Pharm Res. 2015;32(12):3927\u201336.","journal-title":"Pharm Res"},{"issue":"3","key":"8419_CR40","first-page":"88","volume":"93","author":"A Valdivieso","year":"1993","unstructured":"Valdivieso A, Calvo R, Gonzalez J, Mugica J, Suarez E. Influence of several surgical techniques in peptic ulcer disease on the oral kinetic of a basic drug. Acta Chir Belg. 1993;93(3):88\u201391.","journal-title":"Acta Chir Belg"},{"key":"8419_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051511","author":"D Porat","year":"2020","unstructured":"Porat D, Dahan A. Medication management after bariatric surgery: providing optimal patient care. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9051511.","journal-title":"J Clin Med"},{"issue":"8","key":"8419_CR42","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1007\/s11695-019-03885-6","volume":"29","author":"A El-Zailik","year":"2019","unstructured":"El-Zailik A, Cheung LK, Wang Y, Sherman V, Chow DS. Longitudinal impacts of gastric bypass surgery on pharmacodynamics and pharmacokinetics of Statins. Obes Surg. 2019;29(8):2571\u201383.","journal-title":"Obes Surg"},{"issue":"11","key":"8419_CR43","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/obr.12434","volume":"17","author":"C Azran","year":"2016","unstructured":"Azran C, Wolk O, Zur M, Fine-Shamir N, Shaked G, Czeiger D, et al. Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations. Obes Rev. 2016;17(11):1050\u201366.","journal-title":"Obes Rev"},{"issue":"4","key":"8419_CR44","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11239-013-0891-2","volume":"36","author":"A Mahlmann","year":"2013","unstructured":"Mahlmann A, Gehrisch S, Beyer-Westendorf J. Pharmacokinetics of Rivaroxaban after bariatric surgery: a case report. J Thromb Thrombolysis. 2013;36(4):533\u20135.","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"8419_CR45","first-page":"e49","volume":"8","author":"D Lee","year":"2013","unstructured":"Lee D, DeFilipp Z, Judson K, Kennedy M. Subtherapeutic anticoagulation with Dabigatran following Roux-en-Y gastric bypass surgery. J Cardiol Cases. 2013;8(1):e49\u201350.","journal-title":"J Cardiol Cases"},{"issue":"6","key":"8419_CR46","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s11695-013-0882-6","volume":"23","author":"JP Yska","year":"2013","unstructured":"Yska JP, van der Linde S, Tapper VV, Apers JA, Emous M, Tott\u00e9 ER, et al. Influence of bariatric surgery on the use and pharmacokinetics of some major drug classes. Obes Surg. 2013;23(6):819\u201325.","journal-title":"Obes Surg"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-025-08419-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-025-08419-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-025-08419-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:18:50Z","timestamp":1772551130000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-025-08419-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["8419"],"URL":"https:\/\/doi.org\/10.1007\/s11695-025-08419-x","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}